… We also analyzed changes in post-bronchodilator FEV 1 after treatment with prednisone
or prednisolone in the 194 asthma patients for whom the relevant data were available. ( 8 8. …

… Finally, the generalisability of the findings is limited by the original trial inclusion criteria—for
example, many studies required non-smokers with significant bronchodilator reversibility, so …

… Dual bronchodilation therapy is the cornerstone for … bronchodilation and, thus, reduce the
risk of adverse events (AEs). Citation8 Unfortunately, the doses of each single bronchodilator …

… therapy with high-dose albuterol … bronchodilator therapies because of the relatively small
number of patients enrolled in their study. Nonsignificant trends favoring combination therapy …

… In conclusion, the results of our analysis suggest that using beta2AR agonist bronchodilators
based on specific patient characteristics or biomarkers (eg, infants with proasthmatic …

… The current meta-analysis indicated that the use of single inhaler triple therapy for COPD
patients can result in a lower rate of moderate or severe exacerbations of COPD, as well as …

… Thus, therapy with continuous albuterol nebulization was considered to be better than intermittent
therapy … This review analyzed 393 adults who were included in six trials. One study 27 …

… for all clinicians, as theophylline is a common bronchodilator that has been used for decades.1,
27 The aim of this systematic review and meta-analysis, then, was to evaluate the impact …

… an approach often involves combining bronchodilators from different pharmacologic classes.
… various bronchodilators and on recent studies that have examined combination therapy as …

… Long-acting bronchodilators are the cornerstone of pharmacologic treatment of COPD. The
… been introduced as fist line therapy for COPD. This article analyses the evidence of efficacy …